The abstract is read at the publisher; the summary is JClub's.
In a cross-sectional cohort of 211 Parkinson disease participants versus 204 healthy controls, stool/plasma biomarker profiles show no overall PD-control difference, but microbiome/dysbiosis differs (GST P=0.017).
- Why it matters: Most gut-brain-axis work tests single compartments, leaving unclear whether PD reflects broad gut changes or selective gut abnormalities, and whether diagnosis-linked and severity-linked signals overlap.
- What they did: The study profiled 24 stool and plasma biomarkers into an overall profile, three gut-related domains, and eight mechanistic profiles, then used rank-based Global Statistical Tests to compare PD Trait versus State.
- The result: PD severity showed an overall-profile difference (GST P=0.053; permutation P=0.037), with microbiome/dysbiosis (GST P=0.023; permutation P=0.016) and microbial alpha-diversity (GST P=0.027; permutation P=0.031) differing, implying distinct gut processes for diagnosis versus progression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.